Amphetamine Cocaine Interaction Study - 2
Information source: The University of Texas Health Science Center, Houston
ClinicalTrials.gov processed this data on August 20, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Cocaine-Related Disorders
Intervention: Dextroamphetamine (Drug)
Phase: Phase 1
Status: Terminated
Sponsored by: The University of Texas Health Science Center, Houston Official(s) and/or principal investigator(s): John Grabowski, Ph.D., Principal Investigator, Affiliation: University of Texas
Summary
The purpose of this study is to evaluate results of d-amphetamine - cocaine (pharmacology)
interaction study.
Clinical Details
Official title: Amphetamine Cocaine Interaction Study
Study design: Primary Purpose: Treatment
Eligibility
Minimum age: 18 Years.
Maximum age: 45 Years.
Gender(s): Male.
Criteria:
Please contact site for information.
Locations and Contacts
University of Texas Health Science Center, Houston, Texas 77225, United States
Additional Information
Last updated: May 17, 2012
|